Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
About 5% of veterans with dementia had evidence of liver cirrhosis, which can lead to cognitive impairment.
Study findings suggest people with chronic liver disease should be prioritized for booster shots.
The burden of viral and nonviral liver disease remains high even in the setting of hepatitis C microelimination.
People with advanced fibrosis—not just cirrhosis—were at greater risk for hepatocellular carcinoma.
The buildup of fat in the liver can lead to fibrosis, cirrhosis and liver cancer.
Diabetes and a large waist circumference are predictors of liver fat accumulation and fibrosis.
HIV was linked to an increased prevalence of liver fibrosis in a recent study.
Fat in the liver can lead to health complications, including cirrhosis and liver cancer.
Developing treatments for fatty liver disease has proved challenging, and there are currently no approved medications.
As with HIV-negative individuals, non-alcoholic fatty liver disease is tied to diabetes and irregular blood lipids in those with HIV.
About a quarter of people taking a higher dose of Ocaliva saw an improvement in liver fibrosis.
The application is based on study results showing that up to 23% of treated patients saw an improvement in liver fibrosis.
Inflammation in people with HIV is associated with cardiovascular disease and other serious health conditions.
Currently, there are no pharmacological treatments for liver fibrosis related to non-alcoholic steatohepatitis.
Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.
HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.